← Leaderboards
Jonathan R Seals
Glaxosmithkline
$3,489,073
Attributed
$3,489,073
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,489,073 · 1
By mechanism
UC1$3,489,073 · 1
Top collaborators
No co-investigators on record.
Most similar at Glaxosmithkline
Same institution · by research overlap
- John T Lonsdale$9,325,244
- Colin K Ohrt$26,000
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationClinical ResearchCooperative StudyDrug Design /Synthesis /ProductionGrowth MediaHuman SubjectInfluenza VaccinesLaboratory MouseMdck CellTissue /Cell CultureVaccine DevelopmentVaccine Evaluation